Details for Patent: 10,869,845

« Back to Dashboard

Which drugs does patent 10,869,845 protect, and when does it expire?

Patent 10,869,845 protects EPHEDRINE SULFATE and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 10,869,845

Title:	Ephedrine compositions and methods
Abstract:	Disclosed herein are storage-stable ephedrine single-phase solution compositions, comprising 4 mg/mL to 6 mg/mL of ephedrine, a pH adjuster comprising acetic acid, and water, wherein the composition has a pH between 4.5 and 5.0; and wherein the pH drift of the composition is less than 0.5 after storage over at least two months at 25° C. and 60% relative humidity. Also disclosed herein are methods of making and using the same.
Inventor(s):	Irfan Ali Mohammed, Tushar Hingorani, Kumaresh Soppimath
Assignee:	Nevakar Injectables Inc
Application Number:	US16/749,378
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,869,845
Patent Claim Types: see list of patent claims	Composition; Process;

Drugs Protected by US Patent 10,869,845

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ph Health	EPHEDRINE SULFATE	ephedrine sulfate	SOLUTION;INTRAVENOUS	213994-002	Apr 22, 2022	AP2	RX	Yes	Yes			Y
Ph Health	EPHEDRINE SULFATE	ephedrine sulfate	SOLUTION;INTRAVENOUS	213994-001	Oct 16, 2020	AP2	RX	Yes	Yes			Y

International Family Members for US Patent 10,869,845

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
World Intellectual Property Organization (WIPO)	2021150253